Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;

> China-based Burning Rock Biotech raised $23 million in Series A+ finance for efforts to develop diagnostic tests for solid tumor cancers that can indicate the best treatment option, the company said in a press release. Investors included Jifeng Capital, Sequoia Capital and Legend Star. Burning Rock was founded last year and in a Series A round raised $9.7 from Northern Light Venture Capital and Legend Star, an incubator program of Legend Holdings. Release (Chinese language)

> China's Anpac Bio-Medical Science CEO Chris Yu said the medical device maker has secured financing from venture capital firm Shanghai Zhangjiang Science &Technology Investment Corporation equivalent to "several million" dollars to help develop its early cancer detection technology. Release

> Hong Kong-listed 3SBio will be added as a constituent of the Hang Seng LargeCap & MidCap Index on Sep. 14, the company said in a press release. The company listed on the exchange in June of this year, two years after delisting from the U.S. market. Release

> India's Economic Times provided an overview of the country's path in healthcare to mark its 68th Aug. 15 independence day, showing a range of public health milestones. Report

> India's Aurobindo Pharma has plans to build three formulation plants in the southern states of Andhra Pradesh and Telangana to meet expected demand from the U.S. market, Mint newspaper said. Report